Cathal Ó’Brien

536 total citations
23 papers, 233 citations indexed

About

Cathal Ó’Brien is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Cathal Ó’Brien has authored 23 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Cathal Ó’Brien's work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Cathal Ó’Brien is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Cathal Ó’Brien collaborates with scholars based in Ireland, United States and United Kingdom. Cathal Ó’Brien's co-authors include Conleth Feighery, Darren R. Flower, E. C. Sweeney, Stephen P. Finn, John O’Leary, Sarah E. Taylor, Yasir Y. Elamin, Orla Sheils, Pilib Ó Broin and Kenneth J. O’Byrne and has published in prestigious journals such as SHILAP Revista de lepidopterología, Breast Cancer Research and Treatment and Journal of Thoracic Oncology.

In The Last Decade

Cathal Ó’Brien

22 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cathal Ó’Brien Ireland	8	69	62	56	50	45	23	233
Simona Pigozzi Italy	9	101 1.5×	51 0.8×	121 2.2×	51 1.0×	61 1.4×	24	320
Iara Viana Vidigal Santana Brazil	11	73 1.1×	77 1.2×	102 1.8×	67 1.3×	29 0.6×	33	290
Junchang Zhang China	12	113 1.6×	50 0.8×	71 1.3×	59 1.2×	67 1.5×	26	289
Sanyun Wu China	8	130 1.9×	30 0.5×	48 0.9×	82 1.6×	28 0.6×	20	296
Qingzhu Wei China	13	144 2.1×	66 1.1×	65 1.2×	101 2.0×	22 0.5×	34	352
Tomoko Kawabata Japan	10	110 1.6×	65 1.0×	60 1.1×	26 0.5×	108 2.4×	36	428
Anuj Verma India	8	77 1.1×	39 0.6×	103 1.8×	24 0.5×	31 0.7×	36	239
Doris Höflmayer Germany	13	171 2.5×	98 1.6×	84 1.5×	70 1.4×	22 0.5×	22	360
Jamal Carter United States	12	66 1.0×	157 2.5×	69 1.2×	84 1.7×	17 0.4×	19	339
Vasileia Damaskou Greece	10	59 0.9×	20 0.3×	106 1.9×	27 0.5×	40 0.9×	28	276

Countries citing papers authored by Cathal Ó’Brien

Since Specialization

Citations

This map shows the geographic impact of Cathal Ó’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathal Ó’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathal Ó’Brien more than expected).

Fields of papers citing papers by Cathal Ó’Brien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathal Ó’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathal Ó’Brien. The network helps show where Cathal Ó’Brien may publish in the future.

Co-authorship network of co-authors of Cathal Ó’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Cathal Ó’Brien. A scholar is included among the top collaborators of Cathal Ó’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathal Ó’Brien. Cathal Ó’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barr, Martin P., et al.. (2023). Genomic Landscape of NSCLC in the Republic of Ireland. JTO Clinical and Research Reports. 5(2). 100627–100627. 2 indexed citations

Barr, Martin P., Anne‐Marie Baird, Petra Martin, et al.. (2022). Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC. Diagnostics. 12(10). 2360–2360. 3 indexed citations

Perrigoue, Jacqueline, Lin Kooi Ong, Lei Chang, et al.. (2022). P328 In silico evaluation and pre-clinical efficacy of anti-TNF and anti-IL-23 combination therapy in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 16(Supplement_1). i348–i348. 7 indexed citations

Radonic, Teodora, Willemina R.R. Geurts-Giele, Kris G. Samsom, et al.. (2021). RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer. Journal of Thoracic Oncology. 16(5). 798–806. 25 indexed citations

Ó’Brien, Cathal, et al.. (2021). Deep Learning of Histopathological Features for the Prediction of Tumour Molecular Genetics. Diagnostics. 11(8). 1406–1406. 21 indexed citations

Langabeer, Stephen E., et al.. (2020). Prefibrotic Myelofibrosis Presenting with Multiple Cerebral Embolic Infarcts and the Rare MPL W515S Mutation. SHILAP Revista de lepidopterología. 2020. 1–4.

Lee, Greg, Yu Chuan Tai, Cathal Ó’Brien, et al.. (2020). Molecular Subtyping of Diffuse Large B-Cell Lymphoma Using a Novel Quantitative RT-PCR Assay. Journal of Molecular Diagnostics. 23(3). 323–340. 3 indexed citations

O’Toole, Sharon, Cathy Spillane, Yanmei Huang, et al.. (2020). Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 181(3). 571–580. 8 indexed citations

Ó’Brien, Cathal, Niamh Leonard, Siobhan Nicholson, et al.. (2019). Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples. Diagnostics. 9(1). 13–13. 9 indexed citations

10.

Frawley, Thomas F., Cathal Ó’Brien, Eibhlin Conneally, et al.. (2018). Development of a Targeted Next-Generation Sequencing Assay to Detect Diagnostically Relevant Mutations of JAK2 , CALR , and MPL in Myeloproliferative Neoplasms. Genetic Testing and Molecular Biomarkers. 22(2). 98–103. 6 indexed citations

11.

Kelly, Deirdre, Louise Burke, Cathal Ó’Brien, et al.. (2018). Co-occurrence of EGFR sensitising and resistance mutations at diagnosis in NSCLC. Irish Journal of Medical Science (1971 -). 188(2). 405–408. 1 indexed citations

12.

Baird, Anne‐Marie, Niamh M. Keegan, Martin P. Barr, et al.. (2017). MA 04.10 An Assessment of the Willingness to Provide Serial Bio-Specimens: Experience from an Irish Tertiary Cancer Centre. Journal of Thoracic Oncology. 12(11). S1814–S1814. 1 indexed citations

13.

Ó’Brien, Cathal, et al.. (2014). Molecular testing in oncology: Problems, pitfalls and progress. Lung Cancer. 83(3). 309–315. 19 indexed citations

14.

Elamin, Yasir Y., et al.. (2014). Epidermal growth factor receptor (EGFR) mutation testing, from bench to practice: a single institute experience.. PubMed. 107(7). 201–4. 4 indexed citations

15.

Elamin, Yasir Y., Shereen Rafee, Cathal Ó’Brien, et al.. (2013). Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experience. European Archives of Oto-Rhino-Laryngology. 271(8). 2253–2259. 18 indexed citations

16.

Ó’Brien, Cathal, Stephen E. Langabeer, Kenneth J. O’Byrne, John O’Leary, & Stephen P. Finn. (2013). Predictive Values for Molecular Diagnostics: Converting Unknown Unknowns to Known Unknowns. Molecular Diagnosis & Therapy. 18(1). 1–4. 2 indexed citations

17.

Morine, Melissa J., Cathal Ó’Brien, & Helen M. Roche. (2008). Session 2: Personalised nutrition Transcriptomic signatures that have identified key features of metabolic syndrome. Proceedings of The Nutrition Society. 67(4). 395–403. 2 indexed citations

18.

Ó’Brien, Cathal, Darren R. Flower, & Conleth Feighery. (2008). Peptide length significantly influences in vitro affinity for MHC class II molecules. PubMed. 4(1). 6–6. 61 indexed citations

19.

Devadason, David, et al.. (2007). A Renal Consult. Journal of Pediatric Gastroenterology and Nutrition. 44(2). 163–164. 1 indexed citations

20.

Sweeney, E. C., et al.. (1981). Medullary carcinoma of the thyroid presenting as tumours of the pharynx and larynx. Histopathology. 5(3). 263–275. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact